This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Nabriva Therapeutics Ag. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Zrinka Ivezic-Schoenfeld: Pharmaceutical Invention and Patent Work.
Introduction.
Zrinka Ivezic-Schoenfeld is a woman inventor associated with Korneuburg, Austria. Her patent work concerns modified pleuromutilin compounds and their potential pharmaceutical applications.
Latest Patents.
The supplied information lists one patent for Ivezic-Schoenfeld: “12-epi pleuromutilins.” The patent describes compounds based on 12-epi-mutilins, including specified sulfur- or oxygen-linked groups at position 14 and a nitrogen-containing hydrocarbon substituent at position 12. It also covers processes for preparing these compounds and their use as pharmaceuticals. The listed patent count is 1 patent.
Career Highlights.
Ivezic-Schoenfeld is associated with Nabriva Therapeutics AG and Hong Kong King-Friend Industrial Company Limited. The available information does not specify her roles or dates of employment at these companies.
Collaborations.
Rosemarie Riedl and Hermann Kollmann are identified as Ivezic-Schoenfeld’s coworkers. The supplied information does not detail their specific contributions to the patent.
Conclusion.
Zrinka Ivezic-Schoenfeld’s listed invention focuses on 12-epi pleuromutilin compounds, their preparation, and their potential use as pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile